Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Andreas Fontalis, Eustathios Kenanidis, Rafail Angelos Kotronias, Afroditi Papachristou, Panagiotis Anagnostis, Michael Potoupnis & Eleftherios Tsiridis. (2019) Current and emerging osteoporosis pharmacotherapy for women: state of the art therapies for preventing bone loss. Expert Opinion on Pharmacotherapy 20:9, pages 1123-1134.
Read now
Read now
P. Hadji. (2012) The evolution of selective estrogen receptor modulators in osteoporosis therapy. Climacteric 15:6, pages 513-523.
Read now
Read now
Articles from other publishers (32)
Gigi PG, Ankita Chugh, Kirti Chaudhry, Amanjot Kaur, Pravin Kumar, Shubham Gaur, Shailendra Kumar & Surjit Singh. (2022) Comparison of Teriparatide and Combination of Cissus Quadrangularis and Dalbergia Sissoo on Bone Healing Against the Control Group in Maxillofacial Fractures: A Randomized Open-label Control Trial. Craniomaxillofacial Trauma & Reconstruction 16:1, pages 23-33.
Crossref
Crossref
P. J. Roch, V. Wolgast, M.-M. Gebhardt, K. O. Böker, D. B. Hoffmann, D. Saul, A. F. Schilling, S. Sehmisch & M. Komrakova. (2022) Combination of selective androgen and estrogen receptor modulators in orchiectomized rats. Journal of Endocrinological Investigation 45:8, pages 1555-1568.
Crossref
Crossref
M. Komrakova, G. Büchler, K. O. Böker, W. Lehmann, A. F. Schilling, P. J. Roch, S. Taudien, D. B. Hoffmann & S. Sehmisch. (2022) A combined treatment with selective androgen and estrogen receptor modulators prevents bone loss in orchiectomized rats. Journal of Endocrinological Investigation 45:12, pages 2299-2311.
Crossref
Crossref
Hyoeun Jeon, Jungeun Yu, Jung Me Hwang, Hye-Won Park, Jiyeon Yu, Zee-Won Lee, Taesoo Kim & Jaerang Rho. (2022) 1,3-Dibenzyl-5-Fluorouracil Prevents Ovariectomy-Induced Bone Loss by Suppressing Osteoclast Differentiation. Immune Network 22:5.
Crossref
Crossref
Hee Soo Han, Sung Hee Cho, Moon Seok Park, Ki Hyuk Sung & Kyoung Min Lee. (2021) Comparison of Bone Mineral Density and Markers of Bone Turnover in Osteoporotic Women after 6-Month Treatment with Alendronate or Bazedoxifene: A Randomized Controlled Trial. Journal of Bone Metabolism 28:2, pages 131-137.
Crossref
Crossref
N. Binkley, E. Orwoll, R. Chapurlat, B. L. Langdahl, B. B. Scott, H. Giezek & A. C. Santora. (2020) Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis. Osteoporosis International 32:1, pages 173-184.
Crossref
Crossref
Zi Zou, Wei Liu, Lihua Cao, Ying Liu, Tiantian He, Shuping Peng & Cijun Shuai. (2020) Advances in the occurrence and biotherapy of osteoporosis. Biochemical Society Transactions 48:4, pages 1623-1636.
Crossref
Crossref
Wenxiang Chen, Ziang Xie, Pan Tang, Yongli Wang, Zhiwei Jie, An Qin, Xuesheng Jiang, Zhijun Hu & Shunwu Fan. (2019) The emerging role of IMD 0354 on bone homeostasis by suppressing osteoclastogenesis and bone resorption, but without affecting bone formation. Cell Death & Disease 10:9.
Crossref
Crossref
Andy Göbel, Jan D. Kuhlmann, Theresa Link, Pauline Wimberger, Cornelia Link-Rachner, Stefanie Thiele, Stefania Dell'Endice, Giulia Furesi, Dorit Breining, Martina Rauner, Lorenz C. Hofbauer & Tilman D. Rachner. (2019) Plasma levels of Semaphorin 4D are decreased by adjuvant tamoxifen but not aromatase inhibitor therapy in breast cancer patients. Journal of Bone Oncology 16, pages 100237.
Crossref
Crossref
L. Vignozzi, N. Malavolta, P. Villa, G. Mangili, S. Migliaccio & S. Lello. (2018) Consensus statement on the use of HRT in postmenopausal women in the management of osteoporosis by SIE, SIOMMMS and SIGO. Journal of Endocrinological Investigation 42:5, pages 609-618.
Crossref
Crossref
Hye Jung Ihn, Taeho Lee, Doohyun Lee, Jong-Sup Bae, Sang-Hyun Kim, Il Ho Jang, Yong Chul Bae, Hong-In Shin & Eui Kyun Park. (2019) Inhibitory Effect of KP-A038 on Osteoclastogenesis and Inflammatory Bone Loss Is Associated With Downregulation of Blimp1. Frontiers in Pharmacology 10.
Crossref
Crossref
Anwesha Barik & Nishant Chakravorty. 2020. Trends in Biomedical Research. Trends in Biomedical Research
1
17
.
Pierre Maudens, Olivier Jordan & Eric Allémann. (2018) Recent advances in intra-articular drug delivery systems for osteoarthritis therapy. Drug Discovery Today 23:10, pages 1761-1775.
Crossref
Crossref
Silvia Migliaccio, Andrea Lenzi & Emanuela A. Greco. 2018. Multidisciplinary Approach to Osteoporosis. Multidisciplinary Approach to Osteoporosis
285
295
.
Anne Gingery, Urszula T Iwaniec, Malayannan Subramaniam, Russell T Turner, Kevin S Pitel, Renee M McGovern, Joel M Reid, Ronald J Marler, James N Ingle, Matthew P Goetz & John R Hawse. (2017) Skeletal and Uterotrophic Effects of Endoxifen in Female Rats. Endocrinology 158:10, pages 3354-3368.
Crossref
Crossref
Emanuela A. Greco, Silvia Migliaccio, Claudio Marcocci & Elisabetta Romagnoli. (2017) Appropriatezza terapeutica in osteoporosi. L'Endocrinologo 18:4, pages 153-158.
Crossref
Crossref
Andy Göbel, Jan D. Kuhlmann, Theresa Link, Pauline Wimberger, Andrew J. Browne, Martina Rauner, Lorenz C. Hofbauer & Tilman D. Rachner. (2017) Adjuvant tamoxifen but not aromatase inhibitor therapy decreases serum levels of the Wnt inhibitor dickkopf-1 while not affecting sclerostin in breast cancer patients. Breast Cancer Research and Treatment 164:3, pages 737-743.
Crossref
Crossref
E. Raubenheimer, H. Miniggio, L. Lemmer & W. van Heerden. (2017) The Role of Bone Remodelling in Maintaining and Restoring Bone Health: an Overview. Clinical Reviews in Bone and Mineral Metabolism 15:2, pages 90-97.
Crossref
Crossref
Wang Chunxiao, Gu Chengying, Jin Liang, Shi Xiaoming, Guo Feng, Yuan Junting, Wu Wenhui, Wang Yu & Liu Jingjing. (2017) Pharmacological effects of a recombinant hPTH(1−34) derived peptide on ovariectomized rats. European Journal of Pharmacology 794, pages 193-200.
Crossref
Crossref
Priyanka Kushwaha, Vikram Khedgikar, Naseer Ahmad, Anirudha Karvande, Jyoti Gautam, Padam Kumar, Rakesh Maurya & Ritu Trivedi. (2016) A neoflavonoid dalsissooal isolated from heartwood of Dalbergia sissoo Roxb. has bone forming effects in mice model for osteoporosis. European Journal of Pharmacology 788, pages 65-74.
Crossref
Crossref
V. Hegde, J. E. Jo, P. Andreopoulou & J. M. Lane. (2015) Effect of osteoporosis medications on fracture healing. Osteoporosis International 27:3, pages 861-871.
Crossref
Crossref
H. Toumi, D. Benaitreau, S. Pallu, M. Mazor, R. Hambli, M. Ominsky & E. Lespessailles. (2015) Effects of anti-sclerostin antibody and running on bone remodeling and strength. Bone Reports 2, pages 52-58.
Crossref
Crossref
Anne Gingery, Malayannan Subramaniam, Kevin S. Pitel, Jordan M. Reese, Muzaffer Cicek, Laurence B. Lindenmaier, James N. Ingle, Matthew P. Goetz, Russell T. Turner, Urszula T. Iwaniec, Thomas C. Spelsberg & John R. Hawse. (2014) The Effects of a Novel Hormonal Breast Cancer Therapy, Endoxifen, on the Mouse Skeleton. PLoS ONE 9:5, pages e98219.
Crossref
Crossref
Silvia Migliaccio, Rachele Fornari, Emanuela A. Greco, Luigi Di Luigi & Andrea Lenzi. (2013) New therapeutical horizons in the management of postmenopausal osteoporosis. Aging Clinical and Experimental Research 25:S1, pages 117-119.
Crossref
Crossref
Amber Rath Stern & Daniel P. Nicolella. (2013) Measurement and estimation of osteocyte mechanical strain. Bone 54:2, pages 191-195.
Crossref
Crossref
Aoife G. Cotter & Patrick W. G. Mallon. (2012) Therapeutic Options for Low Bone Mineral Density in HIV-Infected Subjects. Current HIV/AIDS Reports 9:2, pages 148-159.
Crossref
Crossref
Steven Boonen, Serge Ferrari, Paul D Miller, Erik F Eriksen, Philip N Sambrook, Juliet Compston, Ian R Reid, Dirk Vanderschueren & Felicia Cosman. (2012) Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk-a perspective. Journal of Bone and Mineral Research 27:5, pages 963-974.
Crossref
Crossref
Juergen Sandow. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Andy ChenPing ZhangZhiyao DuanGuofeng WangHiroki Yokota. (2011) Modelling the Molecular Transportation of Subcutaneously Injected Salubrinal. Biomedical Engineering and Computational Biology 3, pages BECB.S7050.
Crossref
Crossref
Jürgen Sandow. 2011. Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Drug Discovery and Evaluation: Methods in Clinical Pharmacology
489
521
.
Yayoi Izu, Fumitaka Mizoguchi, Aya Kawamata, Tadayoshi Hayata, Testuya Nakamoto, Kazuhisa Nakashima, Tadashi Inagami, Yoichi Ezura & Masaki Noda. (2009) Angiotensin II Type 2 Receptor Blockade Increases Bone Mass. Journal of Biological Chemistry 284:8, pages 4857-4864.
Crossref
Crossref
Carlina V. Albanese & Roberto PassarielloSilvia Migliaccio. 2009. Osteoporosi e malattie metaboliche dell’osso. Osteoporosi e malattie metaboliche dell’osso
521
523
.